Tamoxifen Decreases Fibroblast Function and Downregulates TGFβ2 in Dupuytren's Affected Palmar Fascia
Authors:
- X. WangXWX. Wang
- Wyatt G. PayneWPWyatt G. Payne
- Francis KoFKFrancis Ko
- Martin C. RobsonMRMartin C. Robson
- 1 April 2002
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 103 (2) , 146-152
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Tamoxifen Downregulates TGF-β Production in Keloid FibroblastsAnnals of Plastic Surgery, 1998
- Myofibroblasts of Palmar Fibromatosis co-express transforming growth factor-alpha and epidermal growth factor receptorThe Journal of Pathology, 1997
- The role of transforming growth factor beta in Dupuytren's diseaseThe Journal of Hand Surgery, 1996
- TGFβ and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectinJournal of Molecular Histology, 1995
- Transforming growth factor-β: Possible roles in Dupuytren's contractureThe Journal of Hand Surgery, 1995
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994
- Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fasciaThe Journal of Hand Surgery, 1994
- Transforming growth factor-beta in disease: the dark side of tissue repair.Journal of Clinical Investigation, 1992
- Platelet-derived growth factor in Dupuytren's diseaseThe Journal of Hand Surgery, 1992
- Dupuytren's disease: Comparative growth dynamics and morphology between cultured myofibroblasts (nodule) and fibroblasts (cord)Journal of Orthopaedic Research, 1984